loading
Precedente Chiudi:
$1.69
Aprire:
$1.66
Volume 24 ore:
61,019
Relative Volume:
0.18
Capitalizzazione di mercato:
$76.39M
Reddito:
-
Utile/perdita netta:
$-31.39M
Rapporto P/E:
-2.00
EPS:
-0.84
Flusso di cassa netto:
$-18.45M
1 W Prestazione:
-9.19%
1M Prestazione:
+10.53%
6M Prestazione:
+4.35%
1 anno Prestazione:
+125.87%
Intervallo 1D:
Value
$1.63
$1.70
Intervallo di 1 settimana:
Value
$1.62
$1.87
Portata 52W:
Value
$0.5116
$2.45

Quince Therapeutics Inc Stock (QNCX) Company Profile

Name
Nome
Quince Therapeutics Inc
Name
Telefono
415-910-5717
Name
Indirizzo
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Name
Dipendente
36
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-24
Name
Ultimi documenti SEC
Name
QNCX's Discussions on Twitter

Confronta QNCX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
QNCX
Quince Therapeutics Inc
1.68 88.12M 0 -31.39M -18.45M -0.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-24 Iniziato Oppenheimer Outperform

Quince Therapeutics Inc Borsa (QNCX) Ultime notizie

pulisher
06:51 AM

Using data tools to time your Quince Therapeutics Inc. exitTrend Following Ideas with Volume Confirmation - Newser

06:51 AM
pulisher
04:35 AM

Should you hold or exit Quince Therapeutics Inc. nowAI Intraday Market Movement Prediction Tool - Newser

04:35 AM
pulisher
03:46 AM

What Fibonacci levels say about Quince Therapeutics Inc. reboundDaily Swing Candidate Analysis with Chart Patterns - Newser

03:46 AM
pulisher
03:06 AM

Can trapped investors hope for a rebound in Quince Therapeutics Inc.Free Buy Alerts With Low Risk Confirmation - Newser

03:06 AM
pulisher
Aug 01, 2025

Published on: 2025-08-01 20:05:00 - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

Is Quince Therapeutics Inc. a growth stock or a value stockValue Investing Guidance To Watch Now - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

What are analysts’ price targets for Quince Therapeutics Inc. in the next 12 monthsBreakout Stocks Opportunities Backed By Experts - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Is Quince Therapeutics Inc. stock bottoming outDaily Market Momentum and Pressure Analysis - Newser

Aug 01, 2025
pulisher
Jul 31, 2025

Using RSI to spot recovery in Quince Therapeutics Inc.Free Short Term Buy List With Stop Protection - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What makes Quince Therapeutics Inc. stock price move sharplyAI Generated Buy/Sell Signal Forecast - Newser

Jul 31, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 23:00:54 - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

Exit strategy if you’re trapped in Quince Therapeutics Inc.Free Risk Adjusted Technical Entry Plan - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

How Quince Therapeutics Inc. stock performs during market volatilityReal-Time Market Sentiment Tracking Gains Momentum - beatles.ru

Jul 29, 2025
pulisher
Jul 29, 2025

Wyckoff Accumulation Phase Possible in Quince Therapeutics Inc.Potential Breakout Stock List Published This Week - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

New Product Launches: Will They Boost Quince Therapeutics Inc. Stock in 2025Safe and Scalable Return Strategy Blueprint - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

Sector ETF Data Correlates with Strength in Quince Therapeutics Inc.Intraday Trend Analysis for Fast Gains Released - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Quince Therapeutics Inc. Recovers — But Is It SustainableConservative Entry for High Return Setup Backed - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Quince Therapeutics Inc. stockAchieve rapid wealth accumulation with smart picks - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Quince Therapeutics Inc. company’s growth strategyCapitalize on fast-growing investment opportunities - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Quince Therapeutics Inc.Unlock exclusive trading strategies for gains - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Quince Therapeutics Inc. stock price move sharply Free Intraday Trend Analysis for Fast Gains - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How does Quince Therapeutics Inc. compare to its industry peersFree Stock Movement Tracking - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How Quince Therapeutics Inc. stock performs during market volatility Long Hold Investment Strategy with Growth Focus - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

Why is Quince Therapeutics Inc. stock attracting strong analyst attentionInvest smarter with real-time trading alerts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What catalysts could drive Quince Therapeutics Inc. stock higher in 2025Free Investment Case Studies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Quince Therapeutics Inc.Double or triple returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Has Quince Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewFree Stock Selection - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives $8.00 Average Price Target from Analysts - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

Quince Therapeutics (QNCX) Registers 17.34M Shares for Resale - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Quince Therapeutics Seeks to Resell 17.34M Shares, Analysts Predict 300% Upside Potential - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Quince Therapeutics (QNCX) Plans to Offer 6.67 Million Shares - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Is Quince Therapeutics Inc. a good long term investmentFree Stock Market Knowledge Sharing - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying Quince Therapeutics Inc. stock nowFree Market Dynamics Reports - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Can Quince Therapeutics Inc. stock recover from recent declineConsistent triple returns - jammulinksnews.com

Jul 25, 2025

Quince Therapeutics Inc Azioni (QNCX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Quince Therapeutics Inc Azioni (QNCX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Thye Dirk
CEO AND CHIEF MEDICAL OFFICER
Aug 29 '24
Buy
0.69
77,500
53,475
766,941
Ryan Charles S.
PRESIDENT
Aug 20 '24
Buy
0.65
48,387
31,452
122,461
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Aug 21 '24
Buy
0.63
30,845
19,337
296,540
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Aug 20 '24
Buy
0.60
5,924
3,579
265,695
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Aug 19 '24
Buy
0.58
2,155
1,250
259,771
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Capitalizzazione:     |  Volume (24 ore):